Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Centene Corp (CNC) vs Lufax Holding Ltd (LU) Price & Performance

Centene CorpTrade
Lufax Holding LtdTrade

Price performance (Past 24H)

Key statistics

Centene Corp vs Lufax Holding Ltd — how do they compare? Centene Corp trades at $66.06 (market cap $33.93B), while Lufax Holding Ltd trades at $1.31 (market cap $2.41B). The key difference: Centene Corp is far larger — about 14.1× Lufax Holding Ltd's market cap, and Centene Corp is trading nearer its 52-week high, Lufax Holding Ltd nearer its low. Which is the better fit depends on your goals.

CNCLU
Market Cap
$33.93B$2.41B
Sector
HealthTechnology
52-Week High
$68.72$4.40
52-Week Low
$25.21$1.23
Enterprise Value
$26.56B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Centene Corp

Centene Corporation (CNC) trades at $68.29, up 1.4% with strong technical momentum and bullish moving average signals. The stock shows impressive 66% YTD gains, supported by recent contract renewals and margin recovery initiatives. Despite negative 2025 net income of -$6.67B, valuation metrics remain attractive with P/E of 8.06 and P/S of 0.17. Analyst consensus is strongly bullish with 61% buy ratings and $66.07 price target.

Centene presents a compelling value opportunity with low valuation multiples and strong operational cash flow of $5.09B. Key risks include ongoing margin pressure and Medicaid contract dependency. The company's AI-driven cost controls and recent Illinois Medicaid renewal provide catalysts for earnings recovery, though healthcare regulatory changes remain a concern for long-term stability.

Lufax Holding Ltd

LU trades at $1.25, down 6.72% over 24 hours, with technical indicators signaling a bearish trend. The stock shows weak profitability with a -9.08% net margin and negative ROE of -2.6%, though valuation ratios like P/S of 0.33 and P/B of 0.1 appear low. Recent news highlights multiple class-action lawsuits filed against the company, alleging securities fraud between April 2023 and January 2025.

Outlook remains challenged by legal risks and poor earnings, but low valuations may attract speculative interest. Key risks include ongoing litigation and sustained unprofitability, while analyst consensus leans bullish with 62% buy ratings, suggesting potential recovery if operational improvements materialize.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Centene Corp

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.

Read more on CNC

About Lufax Holding Ltd

Lufax Holding Ltd is a leading financial technology (fintech) platform in China. The company operates a technology-driven personal financial services platform that offers a wide range of loans and wealth management products to its users. Lufax primarily serves the rapidly growing wealth and consumption needs of China’s mass affluent and affluent populations through a combination of its digital platform and an extensive offline network.

Read more on LU